Skip to main content

and
  1. No Access

    Chapter

    Predicting Tofu Productivities of Soybean Varieties by Tofu Gel Centrifugation

    Ten soybean varieties were selected to study their processing properties for tofu. Tofu yields varied from 70.83g to 98.70g per 30g of soybean. The yield of tofu was loosely correlated with the solid content o...

    S.-J. Tsai, T. L. Hong, S. C. S. Tsou in Developments in Food Engineering (1994)

  2. No Access

    Article

    A study of alpha-adrenoceptor gene polymorphisms and Alzheimer disease

    There exists considerable evidence implicating abnormalities of the alpha (α)-adrenergic system in the development of Alzheimer disease (AD). We propose to investigate potential correlations between the prese...

    C.-J. Hong, Y.-C. Wang, T.-Y. Liu, H.-C. Liu, S.-J. Tsai in Journal of Neural Transmission (2001)

  3. No Access

    Article

    Association analysis for genetic variants of the NMDA receptor 2b subunit (GRIN2B) and Parkinson's disease

    Recent studies have implicated N-methyl-D-aspartate (NMDA) receptor dysfunction in the pathogenesis and treatment of Parkinson's disease (PD). The NMDA receptor is composed of several subunits, of which, the ...

    S.-J. Tsai, H.-C. Liu, T.-Y. Liu, C.-Y. Cheng, C.-J. Hong in Journal of Neural Transmission (2002)

  4. No Access

    Article

    Association study of Angiotensin I-converting enzyme polymorphism and symptomatology and antidepressant response in major depressive disorders

    Angiotensin-converting enzyme (ACE) inhibitor has mood-elevating effects, and central ACE activity is increased for suicidal patients. In addition, substance P (SP), which is degraded by ACE, has been implica...

    C.-J. Hong, Y.-C. Wang, S.-J. Tsai in Journal of Neural Transmission (2002)

  5. No Access

    Article

    Association study of the serotonin transporter promoter polymorphism and symptomatology and antidepressant response in major depressive disorders

    The serotonin transporter (5-HTT) is the site of primary action for the selective serotonin reuptake inhibitors (SSRIs). Previous Western reports have demonstrated that the lallele of the 5-HTT gene-linked polymo...

    Y W-Y Yu, S-J Tsai, T-J Chen, C-H Lin, C-J Hong in Molecular Psychiatry (2002)

  6. No Access

    Article

    Association study of the dopamine and serotonin transporter genetic polymorphisms and methamphetamine abuse in Chinese males

    The dopamine transporter (DAT) and the serotonin transporter (5-HTT) play important roles in methamphetamine (METH) dependence because they are the target of METH action. For this study, the association betwe...

    C.-J. Hong, C.-Y. Cheng, L.-R. R. Shu, C.-Y. Yang in Journal of Neural Transmission (2003)

  7. No Access

    Article

    Association studies of the adenosine A2a receptor (1976T > C) genetic polymorphism in Parkinson’s disease and schizophrenia

    Given the implications with respect to the pathogenesis of dopaminergic dysfunction in schizophrenia and Parkinson’s disease (PD), as well as the reciprocal antagonistic interactions between adenosine A2a rece...

    C.-J. Hong, H.-C. Liu, T.-Y. Liu, D.-L. Liao, S.-J. Tsai in Journal of Neural Transmission (2005)

  8. No Access

    Article

    Response to fluoxetine and serotonin 1A receptor (C-1019G) polymorphism in Taiwan Chinese major depressive disorder

    Serotonin systems appear to play a key role in the pathogenesis of major depression and the therapeutic mechanisms of antidepressants. The firing rate of dorsal raphe serotonergic neurons is controlled by soma...

    C-J Hong, T-J Chen, Y W-Y Yu, S-J Tsai in The Pharmacogenomics Journal (2006)

  9. No Access

    Article

    Lack of association of catechol-O-methyltransferase gene Val108/158Met polymorphism with schizophrenia: a family-based association study in a Chinese population

    S-J Tsai, C-J Hong, S-J Hou, F-C Yen in Molecular Psychiatry (2006)

  10. No Access

    Article

    Association study of polymorphisms in glycine transporter with schizophrenia

    Glycine acts as an obligatory co-agonist with glutamate on N-methyl-D-aspartate (NMDA) receptors. Brain glycine availability is determined by glycine transporters (GlyT1 or SLC6A9), which mediate glycine reuptake...

    S.-J. Tsai, C.-Y. Cheng, C.-J. Hong, D.-L. Liao in Journal of Neural Transmission (2006)

  11. No Access

    Article

    Association study of polymorphisms in post-synaptic density protein 95 (PSD-95) with schizophrenia

    The postsynaptic density protein 95 (PSD-95) – the prototype of this family – is a modular protein that enables anchoring of NMDA receptors, modulates NMDA receptor sensitivity to glutamate and coordinates NMD...

    S.-J. Tsai, C.-J. Hong, C.-Y. Cheng, D.-L. Liao in Journal of Neural Transmission (2007)

  12. No Access

    Article

    Glycogen synthase kinase-3β gene is associated with antidepressant treatment response in Chinese major depressive disorder

    Evidence suggests that glycogen synthase kinase-3β (GSK3B) activity is increased significantly in the brain of patients with major depressive disorders (MDD). Inhibition of GSK3B is thought to be a key feature...

    S-J Tsai, Y-J Liou, C-J Hong, Y W-Y Yu, T-J Chen in The Pharmacogenomics Journal (2008)

  13. No Access

    Article

    Gene–gene interactions of the INSIG1 and INSIG2 in metabolic syndrome in schizophrenic patients treated with atypical antipsychotics

    The use of atypical antipsychotics (AAPs) is associated with increasing the risk of the metabolic syndrome (MetS), which is an important risk factor for cardiovascular disease and diabetes. Two insulin-induced...

    Y-J Liou, Y M Bai, E Lin, J-Y Chen, T-T Chen, C-J Hong in The Pharmacogenomics Journal (2012)

  14. Article

    Open Access

    The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

    Response to treatment with selective serotonin reuptake inhibitors (SSRIs) varies considerably between patients. The International SSRI Pharmacogenomics Consortium (ISPC) was formed with the primary goal of id...

    J M Biernacka, K Sangkuhl, G Jenkins, R M Whaley, P Barman in Translational Psychiatry (2015)

  15. Article

    Open Access

    Erratum: The International SSRI Pharmacogenomics Consortium (ISPC): a genome-wide association study of antidepressant treatment response

    Correction to: Translational Psychiatry (2015) 5, e553; doi:10.1038/tp.2015.47; published online 21 April 2015 Following publication, the authors identified an error in the meta-analysis of ISPC, AMPS and STAR...

    J M Biernacka, K Sangkuhl, G Jenkins, R M Whaley, P Barman in Translational Psychiatry (2016)

  16. No Access

    Article

    Targeting TYRO3 inhibits epithelial–mesenchymal transition and increases drug sensitivity in colon cancer

    Colon cancer is the third leading cause of death from cancer worldwide with less than 10% survival rate at the late stage. Although mutations of certain genes have been implicated in familial colon cancer deve...

    C-W Chien, P-C Hou, H-C Wu, Y-L Chang, S-C Lin, S-C Lin, B-W Lin, J-C Lee in Oncogene (2016)

  17. No Access

    Article

    The difficulties in establishing an occupational exposure limit for carbon nanotubes

    Concern over the health effects from the inhalation of carbon nanotubes (CNTs) has been building for some time, and adverse health effects found in animal studies include acute and chronic respiratory damage, ...

    M. Ellenbecker, S-J. Tsai, M. Jacobs, M. Riediker in Journal of Nanoparticle Research (2018)

  18. No Access

    Article

    Co-aggregation of major psychiatric disorders in individuals with first-degree relatives with schizophrenia: a nationwide population-based study

    A previous genetic study has suggested that schizophrenia, bipolar disorder, major depressive disorder, autism spectrum disorder (ASD) and attention deficit hyperactivity disorder (ADHD) share common disease-a...

    C-M Cheng, W-H Chang, M-H Chen, C-F Tsai, T-P Su, C-T Li, S-J Tsai in Molecular Psychiatry (2018)